{
  "ptid_time": "094_S_4434_2012-04-04",
  "img_path": "/data/qiuhui/data/adni/images/094_S_4434/2012-04-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 18,533 mm³, 38.3% below the reference mean. With a Z-score of -0.91 (18.2th percentile), this represents normal volume ; whole brain volume measures 1,017,290 mm³, 10.3% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,673 mm³, 13.8% below the reference mean. With a Z-score of -0.96 (16.9th percentile), this represents normal volume ; fusiform gyrus volume measures 17,339 mm³, 12.9% below the reference mean. With a Z-score of -1.07 (14.2th percentile), this represents mild atrophy; middle temporal gyrus volume measures 21,914 mm³, 2.2% below the reference mean. With a Z-score of -0.18 (42.7th percentile), this represents normal volume . ",
  "text_data": "Age is 66.5 years. Gender is Male. Education: 17 years. MMSE: 30.0. MoCA: 23.0. Logical Memory: 9.0. Laboratory findings: . APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.01 SUVR (normal ); Amyloid beta: 1245.00 pg/mL (normal ); Total tau: 144.60 pg/mL (mild reduced); Phosphorylated tau: 12.73 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild atrophy in whole brain and fusiform gyrus volumes, while other regions are within normal ranges. The MoCA score of 23 suggests mild cognitive impairment (MCI), but the normal Aβ and AV45 (amyloid PET) results, along with reduced tau levels, argue against Alzheimer’s pathology. The absence of APOE4 further reduces Alzheimer’s likelihood.  \n\n**Diagnosis:** **MCI** (likely non-amyloid/non-Alzheimer’s etiology, possibly vascular or other neurodegenerative causes)  \n**Confidence:** **Medium** (due to conflicting biomarkers—low tau and normal amyloid despite cognitive decline)",
  "timestamp": "2025-07-26T10:30:38.704971"
}